Stay updated on Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedA new revision label v3.5.0 has been added and the previous revision v3.4.3 has been removed.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.4.2 was added, and the government funding notice along with Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check47 days agoChange DetectedA government funding lapse notice was added to the page. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check54 days agoChange DetectedAdded Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check68 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. No substantive changes to study content or layout are evident.SummaryDifference0.0%

Stay in the know with updates to Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.